Cargando…

Refining diagnosis of Parkinson's disease with deep learning-based interpretation of dopamine transporter imaging

Dopaminergic degeneration is a pathologic hallmark of Parkinson's disease (PD), which can be assessed by dopamine transporter imaging such as FP-CIT SPECT. Until now, imaging has been routinely interpreted by human though it can show interobserver variability and result in inconsistent diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Hongyoon, Ha, Seunggyun, Im, Hyung Jun, Paek, Sun Ha, Lee, Dong Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610036/ https://www.ncbi.nlm.nih.gov/pubmed/28971009 http://dx.doi.org/10.1016/j.nicl.2017.09.010

Ejemplares similares

Deep learning only by normal brain PET identify unheralded brain anomalies
por: Choi, Hongyoon, et al.
Publicado: (2019)

Unsupervised clustering of dopamine transporter PET imaging discovers heterogeneity of parkinsonism
por: Suh, Minseok, et al.
Publicado: (2020)

Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis
por: Choi, Jinyeong, et al.
Publicado: (2019)

A survey on the interpretability of deep learning in medical diagnosis
por: Teng, Qiaoying, et al.
Publicado: (2022)

Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning
por: Zhao, Yu, et al.
Publicado: (2022)

Processing speed is related to striatal dopamine transporter availability in Parkinson's disease
por: Vriend, Chris, et al.
Publicado: (2020)

Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease
por: Murtomäki, Kirsi, et al.
Publicado: (2022)

Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
por: Fiorenzato, Eleonora, et al.
Publicado: (2021)

Lower (123)I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies
por: Joling, Merijn, et al.
Publicado: (2018)

Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease()
por: Schlaudraff, Falk, et al.
Publicado: (2014)

A pan-cancer analysis of the clinical and genetic portraits of somatostatin receptor expressing tumor as a potential target of peptide receptor imaging and therapy
por: Lee, Hyunjong, et al.
Publicado: (2020)

Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson’s Disease
por: Kim, Han-Joon, et al.
Publicado: (2015)

Dual-phase (18)F-florbetaben PET provides cerebral perfusion proxy along with beta-amyloid burden in Alzheimer’s disease
por: Yoon, Hai-Jeon, et al.
Publicado: (2021)

Deep learning regressor model based on nigrosome MRI in Parkinson syndrome effectively predicts striatal dopamine transporter-SPECT uptake
por: Bae, Yun Jung, et al.
Publicado: (2023)

The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters
por: Nam, Su Bong, et al.
Publicado: (2018)

Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease
por: Caminiti, Silvia Paola, et al.
Publicado: (2017)

Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials
por: Honkanen, Emma A., et al.
Publicado: (2021)

Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients
por: Deutschländer, Angela, et al.
Publicado: (2016)

Chronic exposure to dopamine agonists affects the integrity of striatal D(2) receptors in Parkinson's patients
por: Politis, Marios, et al.
Publicado: (2017)

Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson’s disease
por: van der Vegt, Joyce P.M., et al.
Publicado: (2020)

Electrophysiological resting state networks of predominantly akinetic-rigid Parkinson patients: Effects of dopamine therapy
por: Schneider, Lukas, et al.
Publicado: (2020)

Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
por: Picillo, Marina, et al.
Publicado: (2020)

DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism‐Dystonia
por: Ng, Joanne, et al.
Publicado: (2020)

Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson´s disease: a narrative review
por: Otani, Rafael Tomio Vicentini, et al.
Publicado: (2022)

A Risk Stratification Model for Lung Cancer Based on Gene Coexpression Network and Deep Learning
por: Choi, Hongyoon, et al.
Publicado: (2018)

Identifying controllable cortical neural markers with machine learning for adaptive deep brain stimulation in Parkinson’s disease
por: Castaño-Candamil, Sebastián, et al.
Publicado: (2020)

Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma
por: Park, Changhee, et al.
Publicado: (2020)

Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease
por: Ritz, Beate R., et al.
Publicado: (2009)

Spatiotemporal patterns of putaminal dopamine processing in Parkinson’s disease: A multi-tracer positron emission tomography study
por: Fu, Jessie Fanglu, et al.
Publicado: (2022)

Diagnosis of COVID-19 Pneumonia via a Novel Deep Learning Architecture
por: Zhang, Xin, et al.
Publicado: (2022)

Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases
por: Rieckmann, A., et al.
Publicado: (2015)

Development of Amyloid PET Analysis Pipeline Using Deep Learning-Based Brain MRI Segmentation—A Comparative Validation Study
por: Lee, Jiyeon, et al.
Publicado: (2022)

Clinical outcome prediction from analysis of microelectrode recordings using deep learning in subthalamic deep brain stimulation for Parkinson`s disease
por: Park, Kwang Hyon, et al.
Publicado: (2021)

Interpretable deep learning for automatic diagnosis of 12-lead electrocardiogram
por: Zhang, Dongdong, et al.
Publicado: (2021)

Effects of Deep Brain Stimulation on Sleep-Wake Disturbances in Patients with Parkinson's Disease: A Narrative Review
por: Jung, Yu Jin, et al.
Publicado: (2021)

Prognostic impact of an integrative analysis of [(18)F]FDG PET parameters and infiltrating immune cell scores in lung adenocarcinoma
por: Choi, Jinyeong, et al.
Publicado: (2022)

Mitochondrial Dysfunction in Parkinson's Disease
por: Moon, Hyo Eun, et al.
Publicado: (2015)

The Atypical Dopamine Transporter Inhibitor CE-158 Enhances Dopamine Neurotransmission in the Prefrontal Cortex of Male Rats: A Behavioral, Electrophysiological, and Microdialysis Study
por: Sagheddu, Claudia, et al.
Publicado: (2023)

Interpreting (123)I–ioflupane dopamine transporter scans using hybrid scores
por: Nichols, Kenneth J., et al.
Publicado: (2018)

Dopamine Transporter Loss in 6-OHDA Parkinson’s Model Is Unmet by Parallel Reduction in Dopamine Uptake
por: Chotibut, Tanya, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7bbsjuufekuertfr5n8aianuic